CV Sciences, Inc.
CVSI
$0.03
$0.00-3.11%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.06% | 0.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.06% | 0.39% | |||
| Cost of Revenue | -5.57% | -8.83% | |||
| Gross Profit | -14.37% | 11.22% | |||
| SG&A Expenses | -4.94% | -10.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.87% | 4.34% | |||
| Operating Income | -109.92% | -1,290.91% | |||
| Income Before Tax | -46.36% | -155.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.36% | -139.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.36% | -139.45% | |||
| EBIT | -109.92% | -1,290.91% | |||
| EBITDA | -234.25% | -178.49% | |||
| EPS Basic | -50.00% | -133.33% | |||
| Normalized Basic EPS | -44.44% | -80.00% | |||
| EPS Diluted | -50.00% | -133.33% | |||
| Normalized Diluted EPS | -44.44% | -80.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||